Moneycontrol PRO
HomeNewsPiramal health

Piramal Health

Jump to
  • Aurobindo Pharma, Piramal Health can move up: Murlidharan

    Manoj Murlidharan Vayalar of IIFL is of the view that Aurobindo Pharma can move upto Rs 119 and Piramal Healthcare can touch Rs 523.

  • PMO to take final view on relaxing FDI in pharma: Official

    Prime Minister's Office (PMO)will take a final view on relaxing foreign direct investment norms in the pharmaceutical sector, a senior Finance Ministry official said today.

  • Stocks in news: GVK, Bharti, Gammon Infra, Triveni Engg

    GVK | Bank of Baroda | GTL | GTL Infrastructure | Ranbaxy | MTNL | Piramal Healthcare | Bharti Airtel | Gammon Infra | Triveni Engineering | Managlore Chemical and Geodesic are stocks, which are in the news today.

  • Piramal Health Mar '12 sales at Rs 378.20 crore

    Piramal Healthcare has reported a sales turnover of Rs 378.20 crore and a net loss of Rs 59.43 crore for the quarter ended Mar '12

  • Stocks in news: Vakrangee, Piramal Health, Mukta Arts

    Jet Airways | HCL Infosystems | Vakrangee Software | Ashok Leyland | Piramal Healthcare and Mukta Arts are stocks, which are in the news today.

  • Piramal Health Dec '11 sales at Rs 363.46 crore

    Piramal Healthcare has reported a sales turnover of Rs 363.46 crore and a net loss of Rs 6.33 crore for the quarter ended Dec '11

  • Bull's Eye: Short Kingfisher, RCom; buy GMDC, United Phosp

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Super Six: Manas, Vishal, Rajesh on their top picks

    On CNBC-TV18's show Super Six, market gurus Manas Jaiswal, Technical Analyst, manasjaiswal.com, Vishal Kshatriya, Sr. Derivative and Technical Analyst, Edelweiss and Rajesh Jain, EVP Reatail Research, Religare Sec place their bets on two stocks each, thus offering investors a variety of options to choose from.

  • Piramal Health Sep '11 sales at Rs 331.70 crore

    Piramal Healthcare has reported a sales turnover of Rs 331.70 crore and a net profit of Rs 95.39 crore for the quarter ended Sep '11

  • Piramal Health Jun '11 sales at Rs 255.50 crore

    Piramal Healthcare has reported a sales turnover of Rs 255.50 crore and a net profit of Rs 101.09 crore for the quarter ended Jun '11

  • Stocks in news: Bajaj Auto, Piramal Health, GTL Infra

    Hindustan Copper | Raymond | Bajaj Auto | Piramal Healthcare | Chambal Fertilizers | Jaihind Projects | Wendt India | Orient Ceramics | Prism Cement and Cox & Kings are stocks, which are in the news today.

  • Piramal Health looks attractive: Bhamre

    Piramal Health is looking attractive, says Siddharth Bhamre, Angel Broking.

  • See 5650-5700 by May end on good inflation news: PN Vijay

    Portfolio Manager PN Vijay, in an interview on CNBC-TV18 spoke about his reading of the market. He also gave his views on the assembly election results which are scheduled to be declared on Friday and what impact the results could have on the market and investors.

  • Tulsian's top picks for today: Andhra Bank, Surya Roshni

    SP Tulsian of sptulsian.com, in an interview with CNBC-TV18’s Mitali Mukherjee and Udayan Mukherjee, spoke about his reading of the market and his outlook on a couple of multi-bagger ideas.

  • Stocks in news: Unitech, Piramal Health, KSK Energy, SKS

    PFC | Amrutanjan Health | Unitech | Vardhman Acrylics | Piramal Healthcare | Federal Bank | KSK Energy | SPARC | GE Shipping | Godrej Properties | Piramal Life | Eicher Motors | SKS Microfinance and HUL are stocks, which are in the news today.

  • Bull of the day: Stock that rose 22% in five days

    While the Indian markets have been weak in the last five sessions, Amrutanjan Health Care zoomed 22.21% during the same period. The company board will meet today to consider buy-back of shares, reports CNBC-TV18.

  • Piramal Glass aims to maintain 25% margins

    Ajay Piramal, Chairman of Piramal Group, in an interview with CNBC-TV18’s Latha Venkatesh and Gautam Broker, gave his perspective of the fourth quarter performance and their divulged future plans.

  • Tulsian picks 3 stocks that can fetch you profits

    SP Tulsian of sptulsian.com, in an interview with CNBC-TV18’s Mitali Mukherjee and Sonia Shenoy, spoke about his reading on his picked stocks and the outlook ahead.

  • No triggers to take market past 5,800: Ambareesh Baliga

    Ambareesh Baliga the COO of Way2Wealth in an interview on CNBC-TV18, spoke about his reading of the market and where he sees it headed at this point in time.

  • Bull of the Day: Stock that gained 146% in 9 months

    Wockhardt surged 4.64% or Rs 14.70 to close at Rs 331.65. It touched an intraday high of Rs 341.70 and an intraday low of Rs 318. There were pending buy orders of 720 shares, with no sellers available. The total traded volumes were 503,836 shares. The stock gained 146.21% in nine months

  • Largecap pharma that lost 10% in 2 days

    India's largest pharmaceutical company, Ranbaxy Laboratories has extended its losses further today as it has closed at Rs 461.50, down Rs 32.70, or 6.62%. However, in the yesterday's trading session, the share closed down 3.05% or Rs 15.55 at Rs 494.20.

  • Piramal Health Dec '10 sales at Rs 363.87 crore

    Piramal Healthcare has reported a sales turnover of Rs 363.87 crore and a net profit of Rs 92.02 crore for the quarter ended Dec '10

  • Bull of the Day: Stock that bucked the market trend

    Shasun Chemicals and Drugs gained Rs 3.45 or 5.20% to end at Rs 69.75 on the BSE. It touched an intraday high of Rs 72.20 and an intraday low of Rs 67. There were pending buy orders of 1,993 shares, with no sellers available. The total traded volumes were of 342,183 shares.

  • Bull of the Day: Stock that bucked the trend

    Bal Pharma gained 12.29% or Rs 3.70 to end at Rs 33.80. It touched an intraday high of Rs 35 and an intraday low of Rs 28.40. There were pending buy orders of 2,041 shares, with no sellers available. The total traded volumes were of 99,872 shares.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347